Analysis from multiple databases indicates that the EGF domain-specific O-linked β-N-acetylglucosamine transferase (EOGT) is significantly upregulated in HCC tissue and is associated with poor patient prognosis and drug resistance. This evidence concerns the gene EOGT and hepatocellular carcinoma.